SCH772984
| Title | Journal |
|---|---|
| Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2. | Journal of medicinal chemistry 20180614 |
| Dysregulation of MAP Kinase Signaling Pathways Including p38MAPK, SAPK/JNK, and ERK1/2 in Cultured Rat Cerebellar Astrocytes Exposed to Diphenylarsinic Acid. | Toxicological sciences : an official journal of the Society of Toxicology 20170401 |
| Structure-Guided Design of Highly Selective and Potent Covalent Inhibitors of ERK1/2. | Journal of medicinal chemistry 20150611 |
| Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors. | Cancer discovery 20130701 |